Skip to content

Medical-device intelligence

Hillcrest Biologicals: FDA clearances and recalls

Research Hillcrest Biologicals in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

33 clearance records and 0 recall records in the covered releases, across 1 source company names and 23 product codes. Dated history runs from Apr 5, 1983 to Dec 3, 1992.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

33 matching records
Device / recordCompany in FDA recordSourceSource date
ARBOVIRUS IGG IFA TESTK913617 · GQCHillcrest Biologicals510(k)Dec 3, 1992FDA decision date
ARBOVIRUS IGM IFA TESTK913618 · GQCHillcrest Biologicals510(k)Dec 3, 1992FDA decision date
Q FEVER IGG IFA TESTK913906 · GPJHillcrest Biologicals510(k)Oct 21, 1992FDA decision date
Q FEVER IGM IFA TESTK922374 · GPJHillcrest Biologicals510(k)Oct 21, 1992FDA decision date
LYME DISEASE IGM ELISAK900206 · LSRHillcrest Biologicals510(k)Jun 28, 1991FDA decision date
EBV VCA ANTIBODY (IGM)K896594 · LJNHillcrest Biologicals510(k)Jan 16, 1990FDA decision date
EBV EARLY ANTIGEN (R+D)K884829 · JRYHillcrest Biologicals510(k)Apr 12, 1989FDA decision date
LYME DISEASE IFA (IGM)K883767 · LSRHillcrest Biologicals510(k)Mar 15, 1989FDA decision date
EBV-VCA ANTIBODY (IGG)K884591 · GNPHillcrest Biologicals510(k)Jan 24, 1989FDA decision date
LYME DISEASE IFA (IGG)K883487 · LSRHillcrest Biologicals510(k)Dec 13, 1988FDA decision date
EBNA ANTIBODYK875170 · LLMHillcrest Biologicals510(k)May 23, 1988FDA decision date
LYME DISEASE ELISAK880476 · LSRHillcrest Biologicals510(k)Apr 26, 1988FDA decision date
LEPTOSPIROSIS IHAK880417 · GRYHillcrest Biologicals510(k)Apr 12, 1988FDA decision date
RICKETTSIAL IGG AND IGM IFA KITK864110 · GPNHillcrest Biologicals510(k)Mar 12, 1987FDA decision date
TRANSPORT CULTURE MEDIAK854715 · JSMHillcrest Biologicals510(k)Dec 23, 1985FDA decision date
ECHO TYPE 16 CF ANTIGENK853156 · GNKHillcrest Biologicals510(k)Nov 7, 1985FDA decision date
ECHO TYPE 11 CF ANTIGENK853157 · GNKHillcrest Biologicals510(k)Nov 7, 1985FDA decision date
ECHO TYPE 30 CF ANTIGENK853165 · GNKHillcrest Biologicals510(k)Nov 7, 1985FDA decision date
CMV CF ANTIGENK853277 · GQIHillcrest Biologicals510(k)Nov 7, 1985FDA decision date
POLIO TYPE I CF ANTIGEN, & TYPE II, IIIK853278 · GOGHillcrest Biologicals510(k)Nov 7, 1985FDA decision date
COXSACKIE A2 CF ANTIGEN, A4, A10 & A16K853279 · GNOHillcrest Biologicals510(k)Nov 7, 1985FDA decision date
CMV-IHAK852494 · LJOHillcrest Biologicals510(k)Sep 16, 1985FDA decision date
HILLCREST AMEBIASIS IHA TESTK853448 · KHWHillcrest Biologicals510(k)Aug 28, 1985FDA decision date
HERPES SIMPLEX GROUP CF ANTIGENK850609 · GQNHillcrest Biologicals510(k)May 9, 1985FDA decision date
CELL CULTURE REFEED MEDIUMK850537 · KITHillcrest Biologicals510(k)Mar 20, 1985FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗